Trials / Completed
CompletedNCT01406145
A Study of the Safety and Tolerability of ASP0777 in Subjects With Alzheimer's Disease (AD) Taking a Stable Dose of Donepezil
A Phase 1b, Multicenter, Double-Blind, Randomized, Placebo-Controlled, Sequential Dose Study of the Safety and Tolerability of ASP0777 in Subjects With Alzheimer's Disease on Donepezil
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
This study is intended to determine the safety and tolerability of ASP0777 in subjects with Alzheimer's Disease (AD) taking a stable dose of donepezil.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ASP0777 | oral tablet |
| DRUG | Placebo | oral tablet |
Timeline
- Start date
- 2011-06-16
- Primary completion
- 2011-11-04
- Completion
- 2011-11-04
- First posted
- 2011-08-01
- Last updated
- 2024-10-30
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01406145. Inclusion in this directory is not an endorsement.